SE7612534L - Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning - Google Patents
Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettningInfo
- Publication number
- SE7612534L SE7612534L SE7612534A SE7612534A SE7612534L SE 7612534 L SE7612534 L SE 7612534L SE 7612534 A SE7612534 A SE 7612534A SE 7612534 A SE7612534 A SE 7612534A SE 7612534 L SE7612534 L SE 7612534L
- Authority
- SE
- Sweden
- Prior art keywords
- calcium
- paget
- disease
- pharmaceuticals
- procedure
- Prior art date
Links
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title abstract 3
- 229910052791 calcium Inorganic materials 0.000 title abstract 3
- 239000011575 calcium Substances 0.000 title abstract 3
- 230000007812 deficiency Effects 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 230000002378 acidificating effect Effects 0.000 abstract 3
- 208000010191 Osteitis Deformans Diseases 0.000 abstract 2
- 208000027868 Paget disease Diseases 0.000 abstract 2
- 210000000988 bone and bone Anatomy 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000027202 mammary Paget disease Diseases 0.000 abstract 2
- 238000011287 therapeutic dose Methods 0.000 abstract 2
- 102000055006 Calcitonin Human genes 0.000 abstract 1
- 108060001064 Calcitonin Proteins 0.000 abstract 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 abstract 1
- 229960004015 calcitonin Drugs 0.000 abstract 1
- 230000003913 calcium metabolism Effects 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 230000007928 solubilization Effects 0.000 abstract 1
- 238000005063 solubilization Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752553962 DE2553962A1 (de) | 1975-12-01 | 1975-12-01 | Pharmazeutische praeparate zur behandlung von stoerungen des calciumstoffwechsels |
| DE19752553964 DE2553964A1 (de) | 1975-12-01 | 1975-12-01 | Pharmazeutische praeparate zur behandlung von stoerungen des calciumstoffwechsels |
| DE19752553963 DE2553963A1 (de) | 1975-12-01 | 1975-12-01 | Pharmazeutische praeparate zur behandlung von stoerungen des calciumstoffwechsels |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE7612534L true SE7612534L (sv) | 1977-06-02 |
Family
ID=27186643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7612534A SE7612534L (sv) | 1975-12-01 | 1976-11-10 | Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4086334A (de) |
| AT (1) | AT347578B (de) |
| DK (1) | DK506476A (de) |
| FR (1) | FR2333515A1 (de) |
| GB (1) | GB1571279A (de) |
| NL (1) | NL7612673A (de) |
| SE (1) | SE7612534L (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2432869A1 (fr) * | 1978-08-08 | 1980-03-07 | Armour Montagu Laboratoire | Compositions pour le traitement de l'osteoporose associant la calcitonine et le phosphore |
| US4514331A (en) * | 1983-06-29 | 1985-04-30 | University Patents, Inc. | Peptide hormones with calcitonin-like activity |
| US4663309A (en) * | 1983-06-29 | 1987-05-05 | University Patents, Inc. | Novel peptide hormones with calcitonin-like activity |
| US4639338A (en) * | 1984-08-06 | 1987-01-27 | Ciba-Geigy Corporation | Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate |
| US4687768A (en) * | 1984-12-21 | 1987-08-18 | The Procter & Gamble Company | Certain hexahydroindan-2,2-diphosphonic acids useful in treating diseases associated with abnormal calcium and phosphate metabolism |
| US5104863A (en) * | 1984-12-21 | 1992-04-14 | The Procter & Gamble Company | Certain bicycloalkane and azabicycloalkane-1,1-diphosphonic acid derivatives useful for treating diseases associated with abnormal calcium and phosphate metabolism |
| JPS62185092A (ja) * | 1986-02-07 | 1987-08-13 | Teijin Ltd | 新規ホスホン酸誘導体および除草剤 |
| HU198626B (en) * | 1986-05-27 | 1989-11-28 | Sandoz Ag | Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient |
| US4868164A (en) * | 1986-12-19 | 1989-09-19 | Norwich Eaton Pharmaceuticals, Inc. | Octahydro-pyridine diphosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
| US5139786A (en) * | 1989-07-07 | 1992-08-18 | Ciba-Geigy Corporation | Topical formulations |
| MX21452A (es) * | 1989-07-07 | 1994-01-31 | Ciba Geigy Ag | Preparaciones farmaceuticas que se administran en forma topica. |
| DE3930130A1 (de) * | 1989-09-09 | 1991-03-21 | Boehringer Mannheim Gmbh | Neue amidingruppen-haltige diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| US5760021A (en) * | 1992-05-29 | 1998-06-02 | The Procter & Gamble Company | Phosphonocarboxylate compounds pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
| PT854724E (pt) * | 1995-09-29 | 2005-08-31 | Novartis Ag | Metodo de tratar a doenca navicular em cavalos |
| US5753633A (en) * | 1997-04-11 | 1998-05-19 | Colgate-Palmolive Company | Method of inhibiting bone resorption |
| CN1441674A (zh) * | 2000-09-18 | 2003-09-10 | 福荷福尔丁和考有限公司 | 二磷酸盐溶液 |
| DE10217314A1 (de) * | 2002-04-18 | 2003-11-13 | Fumapharm Ag Muri | Carbocyclische und Oxacarboncyclische Fumarsäure-Oligomere |
| US20040138180A1 (en) * | 2002-10-03 | 2004-07-15 | Barr Laboratories, Inc. | Bisphosphonate composition and process for the preparation thereof |
| WO2005023241A1 (en) * | 2003-09-09 | 2005-03-17 | Fumapharm Ag | The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma |
-
1976
- 1976-11-10 SE SE7612534A patent/SE7612534L/xx not_active Application Discontinuation
- 1976-11-10 DK DK506476A patent/DK506476A/da not_active Application Discontinuation
- 1976-11-15 NL NL7612673A patent/NL7612673A/xx not_active Application Discontinuation
- 1976-11-29 US US05/745,838 patent/US4086334A/en not_active Expired - Lifetime
- 1976-11-30 AT AT885676A patent/AT347578B/de not_active IP Right Cessation
- 1976-11-30 GB GB49882/76A patent/GB1571279A/en not_active Expired
- 1976-12-01 FR FR7636173A patent/FR2333515A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| NL7612673A (nl) | 1977-06-03 |
| US4086334A (en) | 1978-04-25 |
| DK506476A (da) | 1977-06-02 |
| FR2333515B1 (de) | 1980-03-07 |
| ATA885676A (de) | 1978-05-15 |
| FR2333515A1 (fr) | 1977-07-01 |
| AT347578B (de) | 1979-01-10 |
| GB1571279A (en) | 1980-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2162615T3 (es) | Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina. | |
| BR9908030A (pt) | Composição farmacêutica compreendendo uma ou mais unidades de dose oralmente ministráveis, e, processos para prepará-la, para uso da mesma, e para tratar uma condição ou distúrbio médico em um indivìduo em que tratamento com um inibidor da ciclooxigenase-2 é indicado | |
| DE58901401D1 (de) | Pharmazeutische zubereitung zur behandlung des diabetes mellitus. | |
| KR950002785A (ko) | 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜 | |
| ATE157257T1 (de) | Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen | |
| RU92004521A (ru) | Применение бисфосфонатов и экстракта паращитовидных желез для лечения остеопороза и набор для лечения | |
| IL78342A (en) | Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof | |
| PT920865E (pt) | Utilizacao de ""norastemizole"" para o tratamento de disturbios alergicos | |
| ES2136167T3 (es) | Composiciones de idebenona para tratar la enfermedad de alzheimer. | |
| DE69033183D1 (de) | Phosphozucker enthaltende pharmazeutische zubereitung | |
| KR910005858A (ko) | 지방산 요법 | |
| KR890003390A (ko) | 골다공증 및 관련된 장해의 치료방법 | |
| HU9401656D0 (en) | Pharmaceutical composition for treating tumours, containing creatine phosphate or phospho-enol-pyruvic acid | |
| SE9001308L (sv) | Foerfarande foer att behandla och foerebygga foertvining av bensubstans | |
| FR2500303B1 (de) | ||
| IL101675A0 (en) | Method and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors | |
| ES477630A1 (es) | Procedimiento para la obtencion de preparados farmaceuticos desintoxicados de agentes alcohilantes citostaticamente efi-caces. | |
| KR927002224A (ko) | 항종양효과증강제 및 항종양제 | |
| MX2024008330A (es) | Combinacion de obicetrapib e inhibidor de sglt2 | |
| JPS5630917A (en) | Preventive and remedy for hepatitis | |
| KR900701278A (ko) | 바이러스 감염 치료용 담즙산 | |
| DE3275060D1 (en) | Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs | |
| KR880009656A (ko) | 국소 치근막 질환의 치료 또는 예방법 | |
| ATE195868T1 (de) | Pharmazeutische zusammensetzungen von gallium- komplexen von 3-hydroxy-4-pyronen | |
| JPS554397A (en) | Novel n11benzoylln22phenyll1*33diaminopropane 22ol*its manufacture and medicine containing it for therapy of acute and chronic gastritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 7612534-3 Format of ref document f/p: F |